Benralizumab for the Prevention of COPD Exacerbations

Criner, GJ; Celli, BR; Brightling, CE; Agusti, A; Papi, A; Singh, D; Sin, DD; Vogelmeier, CF; Sciurba, FC; Bafadhel, M; Backer, V; Kato, M; Ramirez-Venegas, A; Wei, YF; Bjermer, L; Shih, VH; Jison, M; O'Quinn, S; Makulova, N; Newbold, P; Goldman, M;

Criner, GJ (reprint author), Temple Univ, Lewis Katz Sch Med, Dept Thorac Med & Surg, 3500 N Broad St, Philadelphia, PA 19140 USA.

NEW ENGLAND JOURNAL OF MEDICINE, 2019; 381 (11): 1023

Abstract

Background The efficacy and safety of benralizumab, an interleukin-5 receptor alpha-directed cytolytic monoclonal antibody, for the prevention of exac......

Full Text Link